Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of January 2, 2013
  • Print
  • Share
  • E-mail
-
Back to Previous Page

Event Detail

Event ID 62664
Product Type Drugs
Status Ongoing
Recalling Firm Lloyd Inc. of Iowa
City Shenandoah
State IA
Country US
Voluntary/Mandated Voluntary: Firm Initiated
Recall Initiation Date 2012-07-25
Initial Firm Notification of
Consignee or Public		 Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Distribution Pattern Distribution was nationwide and to Puerto Rico. There was no foreign, military, or government distribution.

Product Detail

Product Description Code Info Classification Reason for Recall Product Quantity Recall Number
Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA. Lot HB23111 and HC23111 Class II Subpotent; 9-month stability interval 3,789,426/50-mcg. tablets D-100-2013
Levothroid (levothyroxine sodium tablets, USP), 50 mcg., 100-count bottles, Rx only, NDC 0456-1321-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA. Lot 1093992 and 1094095, exp. date 9/2012 Class II Subpotent; 9-month stability interval 37,441/100-tablet bottles D-101-2013
Thyro-Tab 0.075 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA Lot HF23111 Class II Subpotent; 9-month stability interval 1,924,133/75-mcg. tablets D-102-2013
Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, Rx only, NDC 0456-1322-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA. Lot 1094098, exp. date 9/2012 Class II Subpotent; 9-month stability interval 16,548/100-tablet bottles D-103-2013
-
-